当前位置: X-MOL 学术Clin. Transl. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
T-cell response after first dose of BNT162b2 SARS-CoV-2 vaccine among healthcare workers with previous infection or cross-reactive immunity
Clinical & Translational Immunology ( IF 4.6 ) Pub Date : 2021-09-08 , DOI: 10.1002/cti2.1341
Jose L Casado 1 , Johannes Haemmerle 2 , Pilar Vizcarra 1 , Mario Rodriguez-Dominguez 3 , Tamara Velasco 1 , Hector Velasco 4 , Elena Centenera 1 , Beatriz Romero-Hernandez 3 , Marina Fernandez-Escribano 2 , Alejandro Vallejo 1, 4
Affiliation  

Antibody response to the first dose of BNT162b2 SARS-CoV-2 is greater in COVID-19-convalescent than in infection-naïve individuals. However, there are no data about T-cell response in individuals with pre-existing cellular immunity.

中文翻译:

先前感染或交叉反应性免疫的医护人员在首剂 BNT162b2 SARS-CoV-2 疫苗后的 T 细胞反应

COVID-19 恢复期患者对第一剂 BNT162b2 SARS-CoV-2 的抗体反应高于未感染者。然而,没有关于预先存在细胞免疫的个体中 T 细胞反应的数据。
更新日期:2021-09-09
down
wechat
bug